| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/22/2005 | CN1207298C Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/22/2005 | CN1207044C Antilipemic antiatherosclerosis medicine composition and preparing method, application thereof |
| 06/22/2005 | CN1207043C Hypotensive and hypolipemic lowering tea |
| 06/22/2005 | CN1207037C Novel usage of Japanese honewort |
| 06/22/2005 | CN1207035C Chinese medicinal vinegar pills for treating heart disease, wind damp disease and cerebrovascular disease |
| 06/22/2005 | CN1207030C Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity |
| 06/22/2005 | CN1207028C Method for preparing 'Antidotal Decoction of Coptidis' solid preparation with combination of film and resin |
| 06/22/2005 | CN1207026C Large-capacity compound red sage root injection and its preparation method |
| 06/22/2005 | CN1207025C Haidan medicine for treating cardiac and cerebral vascular diseases and its prepn |
| 06/22/2005 | CN1207015C Medicinal powder 'Pianfusan' for treating hemiplegia |
| 06/21/2005 | US6909014 Intermediates for the synthesis of ether compounds |
| 06/21/2005 | US6909007 Steroidal pharmaceutical compounds |
| 06/21/2005 | US6908947 Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them |
| 06/21/2005 | US6908943 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/21/2005 | US6908942 Carbocyclic oxy amines such as 2,2-dimethyl-3-(4-fluorobenzyl) ether-4-methoxy-6-(4-methoxybenzyl)amino Benzopyran and libraries, used for prophylaxis of eating disorders induced by lipid peroxidation; antioxidants |
| 06/21/2005 | US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/21/2005 | US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors |
| 06/21/2005 | US6908923 Compositions and methods for treating heart failure |
| 06/21/2005 | US6908922 Linear cyclic ureas |
| 06/21/2005 | US6908920 Pyrimidine derivatives |
| 06/21/2005 | US6908917 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/21/2005 | US6908902 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 06/21/2005 | US6908622 Optimized dosing for drug coated stents |
| 06/21/2005 | US6908614 Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| 06/21/2005 | US6908609 Removing fluid from the intestinal tract of a host by directly delivering an effective amount of water-absorbent polymer to the intestinal tract |
| 06/21/2005 | CA2382387C Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 06/21/2005 | CA2250372C 6-phenylpyridyl-2-amine derivatives |
| 06/21/2005 | CA2108068C Carbamates of rapamycin |
| 06/17/2005 | CA2479432A1 Thiazole derivatives |
| 06/16/2005 | WO2005054432A2 Gene transfer for regulating smooth muscle tone |
| 06/16/2005 | WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 06/16/2005 | WO2005054196A1 A Method for the Enantiomoeric Separation of Optical Active Amlodipine |
| 06/16/2005 | WO2005053730A1 Therapeutic agent for terminal heart failure |
| 06/16/2005 | WO2005053724A1 Compositions and method for treatment of steroid/nuclear receptor-mediated diseases |
| 06/16/2005 | WO2005037928A3 Compounds for dual photodiagnosis and therapy |
| 06/16/2005 | WO2005032559A8 Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 06/16/2005 | WO2004050013A3 Material compositions and related systems and methods for treating cardiac conditions |
| 06/16/2005 | WO2004048565A9 Apoptosis-associated protein and use thereof |
| 06/16/2005 | WO1991001624A8 Use of calcium antagonists for treating scars |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131237 Indole derivatives |
| 06/16/2005 | US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases |
| 06/16/2005 | US20050131200 Biocompatability; polyphosphoester/polyphosphoramidate linkages; improved gene delivery into muscles; DNA vaccines |
| 06/16/2005 | US20050131052 Useful in treatment of type 2 diabetes, insulin resistance, syndrome X, hyperinsulinaemia, hyperglucagonaemia, cardiac ischaemia and obesity |
| 06/16/2005 | US20050131047 cardiovascular disorders |
| 06/16/2005 | US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 06/16/2005 | US20050131040 Reacting losartan and poltassium compound in presence of water and aprotic solvent; salt formation |
| 06/16/2005 | US20050131039 Benzimidazole derivatives, their production and use |
| 06/16/2005 | US20050131038 Process for the preparation of valsartan and intermediates thereof |
| 06/16/2005 | US20050131035 Medicaments |
| 06/16/2005 | US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 06/16/2005 | US20050131024 Antiinflammatory agents; autoimmune diseases; anticancer agents |
| 06/16/2005 | US20050131016 Chemical compounds |
| 06/16/2005 | US20050131015 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 06/16/2005 | US20050131005 4-azasteroid derivatives as androgen receptor modulators |
| 06/16/2005 | US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
| 06/16/2005 | US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents |
| 06/16/2005 | US20050130996 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 06/16/2005 | US20050130981 Compounds |
| 06/16/2005 | US20050130978 Novel crystal of quinoxalinedione derivative anhydride |
| 06/16/2005 | US20050130975 Phthalazine, hydralazine derivative; antihypertensive; extended shell life |
| 06/16/2005 | US20050130965 Inhibitors of p38 kinase |
| 06/16/2005 | US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis |
| 06/16/2005 | US20050130963 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 06/16/2005 | US20050130948 Therapeutic methods and uses of sapogenins and their derivatives |
| 06/16/2005 | US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade |
| 06/16/2005 | US20050130941 Methods of treating alzheimer's disease |
| 06/16/2005 | US20050130929 For introduction of a disc prosthesis or implant; involves providing substance(s) beneficial to the intervertebral disc through a cannulated element |
| 06/16/2005 | US20050130927 For treating neoplasm, hypoproliferation, hyperproliferation, degenerative and neurodegenerative diseases, ischaemia, immune system disorder, infectious disease, or metabolic dysfunction |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
| 06/16/2005 | US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 06/16/2005 | US20050130880 zinc(II) organic complex with ligands selected from aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, alpha - and beta -hydroxycarboxylic acids, vitamins, glutamine; insulin mimetics; less toxic; |
| 06/16/2005 | US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050130136 Cardiovascular disease diagnostic and therapeutic targets |
| 06/16/2005 | US20050129739 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 06/16/2005 | US20050129736 Compositions and methods for treating or preventing diseases of body passageways |
| 06/16/2005 | US20050129691 Using A beta antibody antagonist eg immunoglobulin; obsessive-compulsive disorder, panic disorder, panic attack, agoraphobia, post-traumatic stress disorder, social phobia, disruptive behavior disorder, and chronic fatigue syndrome |
| 06/16/2005 | US20050129665 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 06/16/2005 | US20050129663 Cellular therapy; for promoting axonal regeneration in the CNS, wound healing and treatment of myocardial infarction and spinal cord injury |
| 06/16/2005 | CA2548454A1 Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 06/16/2005 | CA2548129A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| 06/16/2005 | CA2548127A1 Nitrooxyderivatives of antihypertensive drugs |
| 06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
| 06/16/2005 | CA2547791A1 Therapeutics use of pyridinium compounds to modulate naadp activity |
| 06/16/2005 | CA2547551A1 Diazabicyclononene and tetrahydropyridine derivatives with a new side-chain |
| 06/16/2005 | CA2547547A1 Diazabicyclononene derivatives and their use as renin inhibitors |
| 06/15/2005 | EP1541677A1 Novel proteins and use thereof |
| 06/15/2005 | EP1541672A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2005 | EP1541576A1 Furoisoquinoline derivative and use thereof |
| 06/15/2005 | EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient |
| 06/15/2005 | EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative |
| 06/15/2005 | EP1541571A1 Bicyclic unsaturated tertiary amine compound |
| 06/15/2005 | EP1541570A1 Novel physiologically active substance |
| 06/15/2005 | EP1541564A1 Five-membered heterocyclic compounds |
| 06/15/2005 | EP1541563A1 Ccr4 antagonist and medicinal use thereof |
| 06/15/2005 | EP1541559A1 5-substituted isoquinoline derivative |